The University of Chicago Header Logo

Connection

Mark J. Ratain to Maytansine

Back to Details
This is a "connection" page, showing publications Mark J. Ratain has written about Maytansine.
Mark J. Ratain
Connection Strength
0.241
Maytansine
  1. A phase I study of cantuzumab mertansine administered as a single intravenous infusion once weekly in patients with advanced solid tumors. Clin Cancer Res. 2004 Jul 01; 10(13):4363-8.
    View in: PubMed
    Score: 0.241
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.